Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Is intraoperative touch imprint cytology indicated in the surgical treatment of early breast cancers?

Horváth Z, Paszt A, Simonka Z, Látos M, Oláh V, Nagyszegi D, Kaizer L, Fejes Z, Hamar S, Csörgő E, Ormándi K, Lázár M, Lázár G.

Eur J Surg Oncol. 2017 Jul;43(7):1252-1257. doi: 10.1016/j.ejso.2017.01.003. Epub 2017 Jan 18.

PMID:
28139361
2.

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial.

Davison K, Chen BE, Kukreti V, Couban S, Benger A, Berinstein NL, Kaizer L, Desjardins P, Mangel J, Zhu L, Djurfeldt MS, Hay AE, Shepherd LE, Crump M.

Ann Oncol. 2017 Mar 1;28(3):622-627. doi: 10.1093/annonc/mdw653.

PMID:
27993811
3.

Postnatal outcome and placental blood flow after plasmapheresis during pregnancy.

Jakó M, Surányi A, Janáky M, Klivényi P, Kaizer L, Vécsei L, Bártfai G, Németh G.

J Matern Fetal Neonatal Med. 2016 Dec 7:1-4. doi: 10.1080/14767058.2016.1262344. [Epub ahead of print]

PMID:
27924673
4.

Using Data From Ontario's Episode-Based Funding Model to Assess Quality of Chemotherapy.

Kaizer L, Simanovski V, Lalonde C, Tariq H, Blais I, Evans WK.

J Oncol Pract. 2016 Oct;12(10):e870-e877.

PMID:
27858565
5.

A multi-method review of home-based chemotherapy.

Evans JM, Qiu M, MacKinnon M, Green E, Peterson K, Kaizer L.

Eur J Cancer Care (Engl). 2016 Sep;25(5):883-902. doi: 10.1111/ecc.12408. Epub 2015 Nov 6. Review.

PMID:
26545409
6.

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators.

Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016/S1470-2045(15)00086-8. Epub 2015 Jun 23.

7.

Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer.

Enright K, Grunfeld E, Yun L, Moineddin R, Ghannam M, Dent S, Eisen A, Trudeau M, Kaizer L, Earle C, Krzyzanowska MK.

J Oncol Pract. 2015 Mar;11(2):126-32. doi: 10.1200/JOP.2014.001073. Epub 2015 Jan 20.

PMID:
25604597
8.

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.

Crump M, Kuruvilla J, Couban S, MacDonald DA, Kukreti V, Kouroukis CT, Rubinger M, Buckstein R, Imrie KR, Federico M, Di Renzo N, Howson-Jan K, Baetz T, Kaizer L, Voralia M, Olney HJ, Turner AR, Sussman J, Hay AE, Djurfeldt MS, Meyer RM, Chen BE, Shepherd LE.

J Clin Oncol. 2014 Nov 1;32(31):3490-6. doi: 10.1200/JCO.2013.53.9593. Epub 2014 Sep 29.

PMID:
25267740
9.

International efforts in health care reform: systemic treatment funding model reform in Ontario.

Kaizer L, Simanovski V, Blais I, Lalonde C, Evans WK.

J Oncol Pract. 2014 May;10(3):190-2. doi: 10.1200/JOP.2014.001389. No abstract available.

PMID:
24839279
10.

Using breakthrough series collaborative methodology to improve safe delivery of chemotherapy in Ontario.

Simanovski V, Green E, Meertens E, Kaizer L, Ahmad N, Hertz S, Cheng R, Burns J, Krzyzanowska MK.

J Oncol Pract. 2014 Jul;10(4):e240-6. doi: 10.1200/JOP.2013.001254. Epub 2014 Apr 8.

PMID:
24715267
11.

Oral chemotherapy practices at Ontario cancer centres.

Ahmad N, Simanovski V, Hertz S, Klaric G, Kaizer L, Krzyzanowska MK.

J Oncol Pharm Pract. 2015 Aug;21(4):249-57. doi: 10.1177/1078155214528830. Epub 2014 Apr 8.

PMID:
24714129
12.

Lost in transition? Thoughts on retirement--"will you still need me, will you still feed me, when i'm sixty-four?".

Clemons MJ, Vandermeer LA, Gunstone I, Jacobs C, Kaizer L, Paterson AH.

Oncologist. 2013;18(11):1235-8. doi: 10.1634/theoncologist.2013-0173. Epub 2013 Sep 16. No abstract available.

13.

Use of continuous infusion pumps during radiation treatment.

Bak K, Gutierrez E, Lockhart E, Sharpe M, Green E, Costa S, Hertz S, Kaizer L, Whitton A, Warde P.

J Oncol Pract. 2013 Mar;9(2):107-11. doi: 10.1200/JOP.2012.000717. Review.

14.

Birth prevalence of neural tube defects: a population-based study in South-Eastern Hungary.

Szabó N, Gergev G, Valek A, Eller J, Kaizer L, Sztriha L.

Childs Nerv Syst. 2013 Apr;29(4):621-7. doi: 10.1007/s00381-012-1951-1. Epub 2012 Oct 30.

PMID:
23108919
15.

Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.

Füvesi J, Hanrieder J, Bencsik K, Rajda C, Kovács SK, Kaizer L, Beniczky S, Vécsei L, Bergquist J.

Int J Mol Sci. 2012;13(6):7676-93. doi: 10.3390/ijms13067676. Epub 2012 Jun 21.

16.

The relationship of multifocality and tumor burden with various tumor characteristics and survival in early breast cancer.

Kelemen G, Farkas V, Debrah J, Ormandi K, Voros A, Kaizer L, Varga Z, Lazar G, Kahan Z.

Neoplasma. 2012;59(5):566-73. doi: 10.4149/neo_2012_073.

PMID:
22668023
17.

Surgical management of a suspicious adnexal mass: a systematic review.

Covens AL, Dodge JE, Lacchetti C, Elit LM, Le T, Devries-Aboud M, Fung-Kee-Fung M; Gynecology Cancer Disease Site Group.

Gynecol Oncol. 2012 Jul;126(1):149-56. doi: 10.1016/j.ygyno.2012.04.018. Epub 2012 Apr 19. Review.

PMID:
22522189
18.

Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis.

Dodge JE, Covens AL, Lacchetti C, Elit LM, Le T, Devries-Aboud M, Fung-Kee-Fung M; Gynecology Cancer Disease Site Group.

Gynecol Oncol. 2012 Jul;126(1):157-66. doi: 10.1016/j.ygyno.2012.03.048. Epub 2012 Apr 6. Review.

PMID:
22484399
19.

A phase 3 trial of bevacizumab in ovarian cancer.

Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators.

N Engl J Med. 2011 Dec 29;365(26):2484-96. doi: 10.1056/NEJMoa1103799. Erratum in: N Engl J Med. 2012 Jan 19;366(3):284.

20.

Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.

Nikolényi A, Sükösd F, Kaizer L, Csörgo E, Vörös A, Uhercsák G, Ormándi K, Lázár G, Thurzó L, Brodowicz T, Kahán Z.

Oncology. 2011;80(3-4):269-77. doi: 10.1159/000329038. Epub 2011 Jul 7.

PMID:
21734419

Supplemental Content

Loading ...
Support Center